Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Last Updated: May 28, 2023

Chartwell Rx Company Profile

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

What is the competitive landscape for CHARTWELL RX, and what generic and branded alternatives to CHARTWELL RX drugs are available?

CHARTWELL RX has one hundred and ninety-six approved drugs.

Summary for Chartwell Rx

US Patents:	0
Tradenames:	136
Ingredients:	128
NDAs:	196

Drugs and US Patents for Chartwell Rx

+ Get email alerts for changes to this table

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Chartwell Rx	ATOVAQUONE	atovaquone	SUSPENSION;ORAL	207833-001	Apr 28, 2017	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Chartwell Rx	GLIPIZIDE	glipizide	TABLET;ORAL	074542-002	Jun 20, 1995		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
Chartwell Rx	ALENDRONATE SODIUM	alendronate sodium	TABLET;ORAL	075871-002	Apr 22, 2009		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
Chartwell Rx	PREDNISOLONE	prednisolone	TABLET;ORAL	084542-001	Approved Prior to Jan 1, 1982		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
Chartwell Rx	FULVICIN P/G	griseofulvin, ultramicrocrystalline	TABLET;ORAL	061996-002	Approved Prior to Jan 1, 1982		RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Chartwell Rx	SIMVASTATIN	simvastatin	TABLET;ORAL	077766-002	Dec 20, 2006		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter

Merck

Mallinckrodt

AstraZeneca

Express Scripts

Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.